source
- Multispecific drug design faces growing complexity as more binding arms increase molecular optionsThe industry is seeing a rapid rise in complex biologic formats such as trispecific antibodies and cell-engaging molecules. As these multispecific constructs multiply, drug developers are turning t…
- ESMO 2026 preview spotlights upcoming abstracts from Zai Lab, GSK and MerckThe European Society for Medical Oncology (ESMO) meeting returns to Madrid in 2026, featuring a slate of abstracts expected from several major biotech and pharmaceutical companies. Among the antic…